Background. Cardiovascular disease is the major cause of morbidity and mortality after renal transplantation. It has been shown that both traditional and transplant-specific risk factors contribute to the high cardiovascular burden after renal transplantation The aim is to evaluate the association among ambulatory blood pressure monitoring (ABPM) at 3 months, inflammation and graft outcome. Methods. ABPM at 3 months was performed in 126 consecutive renal transplants. According to the nocturnal reduction of systolic blood pressure (SBP), dipper (DSBP ! 10%), non-dipper (0 < DSBP < 10%) and reverse dipper (SBP nocturnal rise) pattern were defined. The outcome variable was the combination of any cardiovascular event and graft failure for any reason. Results. Circadian blood pressure pattern was dipper (n ¼ 22), non-dipper (n ¼ 65) and reverse dipper (n ¼ 39). Reverse dipper pattern was associated with pretransplant diabetes (18 versus 2%, P ¼ 0.004), body mass index (26.9 6 5.0 versus 24.8 6 3.8 kg/m 2 , P ¼ 0.001), calcineurin inhibitor treatment (74 versus 54%, P ¼ 0.001) and serum soluble tumour necrosis factor receptor 2 levels (18 6 15 versus 11 6 6 ng/mL, P ¼ 0.010). During 45 6 11 months of follow-up, 22 patients reached the combined outcome variable. Multivariate Cox regression analysis showed that reverse dipper pattern [relative risk (RR): 3.50 and 95% confidence interval (CI): 1.36-8.93; P ¼ 0.009] and creatinine clearance (RR: 0.94 and 95% CI: 0.91-0.98, P ¼ 0.003) were independently associated with outcome. Conclusion. The reverse dipper circadian pattern is associated with inflammation and constitutes an independent predictor of graft outcome.
Introduction
Cardiovascular disease (CVD) is the major cause of morbidity and mortality after renal transplantation. It has been shown that both traditional risk factors and transplantspecific cardiovascular risk factors contribute to the high CVD burden after renal transplantation [1] . Hypertension is the most prevalent traditional cardiovascular risk factor in kidney transplant recipients, affecting 75-90% of them, and it is associated with poor patient and graft survival [2, 3] .
Although the pathophysiology of hypertension is still unknown, emerging studies have shown that systemic inflammation contributes to its development and increases the risk of CVD [4, 5] . The association between inflammation and CVD is especially evident in patients with endstage renal disease (ESRD). Despite the fact that classical markers of chronic inflammation decrease after transplantation [6] , systemic inflammation remains increased in stable grafts until at least 18 months after transplantation [7] and pre-transplant inflammation has been associated with long-term graft outcomes in renal transplants [8] .
Accurate diagnosis of hypertension is relatively poor due to the limitations of office blood pressure (BP). Ambulatory blood pressure monitoring (ABPM) allows the non-invasive measurement of BP over a prolonged period of time. It has become increasingly popular in the assessment of hypertensive patients as it provides a more reproducible estimate than a single measurement and it is relatively free from side effects. ABPM also provides information about circadian pattern and accordingly, hypertensive subjects can be divided on the basis of their BP dip from day to night into dippers, non-dippers and reverse dippers [9] .
In the field of hypertension, prospective studies showed that information obtained from ABPM provides a better prediction of major cardiovascular events than office BP measurements. Additionally, the loss of circadian BP has also been linked to a higher incidence of cardiovascular events [10] . The association between non-dipping status and CVD is even stronger in ESRD. In this regard, nondipping pattern in chronic haemodialysis patients has been also associated with CVD [11] . Recently, a prospective study conducted in a large cohort of patients with chronic kidney disease has confirmed that ABPM and, in particular, nigh-time BP measurements allow an accurate prediction of renal and cardiovascular risk, while office measurements of BP do not predict outcome [12] . This result suggests that ABPM should be performed not only in patients with symptomatic or unpredictable BP but also in patients with high renal and cardiovascular risk [13] .
In renal transplant recipients, there are few reports evaluating the best method to assess BP. In previous studies, it has been reported that ABPM is probably superior to office BP in order to assess the true BP [14, 15] . Recently, different clinical variables such as patient age, diabetes or lower graft function have been associated with the lack of normal circadian BP pattern [16] . However, there are no data about the influence of circadian pattern on CV events or graft survival after renal transplantation. Thus, we conducted a prospective study to assess the utility of ABPM and office BP to predict CV events or graft failure after renal transplantation.
Materials and methods

Patients
Between March 2005 and October 2006, consecutive kidney transplants performed at Hospital Universitari Bellvitge were invited to participate in a prospective study to evaluate cardiovascular risk, abnormalities of the glucose metabolism, sub-clinical inflammation and atheromatosis progression [6] . Written informed consent was obtained from all patients and the Ethics Committee of our hospital approved this study.
The following traditional cardiovascular risk factors were considered: age and gender of the donor and the recipient, weight and height of the recipient, body mass index (BMI) calculated as weight (kg) divided by squared height (m 2 ), office BP, total serum cholesterol, tobacco smoking, diabetes mellitus and history of cardiovascular events before transplantation.
Transplant-specific variables were also evaluated at the time of surgery: type of renal replacement therapy and dialysis vintage, number of transplants, single or dual transplantation, presence of hepatitis C virus antibodies, last panel-reactive antibodies, number of human leukocyte antigen (HLA) mismatches, cold ischaemia time and immunosuppressive therapy. Induction immunosuppression therapy was recorded as (i) thymoglobulin, (ii) Interleukin 2 receptor antibodies, either basiliximab or daclizumab and (iii) non-induction therapy. Maintenance immunosuppression was grouped as (i) cyclosporine associated with mycophenolate mofetil (MMF), (ii) tacrolimus associated with MMF, (iii) sirolimus associated with MMF, (iv) cyclosporine associated with everolimus and (v) belatacept and MMF. In all regimens, steroid therapy consisted of a 500 mg methylprednisolone bolus the day of surgery, 125 mg the day after transplantation and 20 mg/day thereafter that were tapered to 15 mg at 1 month, 10 mg at 3 months and 0.1 mg/kg/day at 6 months. For this study, initial and 3 months immunosuppression and prednisone dose at 1 week, 1 and 3 months were recorded.
After surgery, the presence of delayed graft function, acute rejection, fatal or non-fatal cardiovascular events, death with function and graft loss and were recorded. Delayed graft function was defined as the need for dialysis during the first week once vascular or ureteral complications were ruled out. Biopsy-proven acute rejection was defined according to Banff criteria [17] . In patients with an acute rise of serum creatinine >20% without a diagnostic biopsy, rejection was diagnosed if serum creatinine decreased after anti-rejection therapy. Creatinine clearance was calculated according to Cockroft and Gault formula. Cardiovascular events were defined as any episode of ischaemic heart disease, cerebrovascular disease, peripheral vascular disease or congestive heart failure.
Anti-hypertensive treatment was prescribed according to the clinician criteria managing individual patients and, in general, following the recommendations of the consensus document published by the Spanish Society of Nephrology [18] .
Ambulatory blood pressure monitoring ABPM was performed 3 months after renal transplantation using an overnight-automated ABPM monitor (Dyasis Integra II, Novacor). BP was measured in the contralateral arm to the arteriovenous fistula with appropriate cuff sizes for each patient. Routine ABPM was performed for 24 h and BP was recorded and stored automatically every 15 min during awake hours and every 30 min during nocturnal hours. From the BP monitor, data using the GARAPA (Gestión y Análisis de Registros Ambulatorios de Presión Arterial) programme [19] , we derived the average 24-h systolic blood pressure (SBP) and diastolic blood pressure (DBP), the awake SBP and DBP, sleep SBP and DBP and pulse pressure.
ABPM hypertension was defined as daytime BP >135/85 mmHg, night-time BP >120/75 mmHg or 24 h BP >130/80 mmHg.
On the basis of percentage reduction in the circadian BP, patients were classified into dippers (DSBP ! 10%), non-dippers (0 < DSBP < 10%) and reverse dippers (nocturnal rise in SBP).
Office BP SBP and DBP were measured in the outpatient clinic after 10 min rest in the contralateral arm of the arteriovenous fistula with an Omron M3 Digital Automatic Monitor. Office hypertension was defined as BP >140/90 mmHg.
Patients with controlled ABPM and uncontrolled office BP were defined as white-coat hypertension and patients with uncontrolled ABPM and controlled office BP were considered as masked hypertension.
Inflammation markers
Two serum systemic inflammation markers were chosen for the present study: soluble tumour necrosis factor receptor 2 (sTNFR2), a marker of monocyte activation, and neutrophil gelatinase-associated lipocalin (NGAL), a marker of neutrophil degranulation. A baseline blood sample was obtained when the patient arrived at the renal transplant unit before performing dialysis and additional blood samples were obtained at 1 and 3 months. Blood samples were centrifuged at 3000 r.p.m. during 10 min and serum and plasma samples were aliquoted and stored at À80°C.
Serum sTNFR2 concentration was measured by sTNFR2 EASIATM ELISA kit (Biosource Europe S.A., Belgium). Serum NGAL concentration was measured by NGAL Elisa Kit (AntibodyShop, Denmark). Intraand inter-assay co-efficients of variation for all these determinations were between 5 and 10%.
Statistics
Continuous normally distributed variables are presented as mean AE SD. To compare categorical, ordinal or non-normally distributed variables and continuous normally distributed variables, chi-squared, Kruskal-Wallis test and analysis of variance (ANOVA) were employed, respectively. Scheffe's test was employed for individual comparison between groups after ANOVA. To compare serum levels of inflammation markers in reverse dipper patients and dipper/non-dipper patients Student's t-test was employed. Univariate and multivariate logistic regression analysis was employed to evaluate variables associated with reverse dipper status.
Univariate and stepwise multivariate regression analysis were employed to analyse the relationship between inflammation markers and clinical variable. For multivariate analysis, qualitative variables were transformed into dummy variables.
For the present study, the primary outcome variable was defined as a composite variable including the appearance of any cardiovascular event and graft loss for any reason. The time elapsed to reach the first of any of these two events for uncensored observations and the last follow-up for censored observations was considered the survival time. To analyse clinical variables associated with the outcome variable, Kaplan-Meier analysis was employed and log rank test was used to compare between groups. Univariate and multivariate Cox regression analysis were employed to estimate risk associated with clinical variables including ABPM data. Statistical analysis was performed with Statview 5.0.1 software. To calculate the power of the association between reverse dipper pattern and the combined outcome variable we used the software available at http:// www.stattools.net.
All tests were two-tailed and a P-value <0.05 was considered significant.
Results
Patients
One hundred and twenty-six Caucasian patients were included in this study. Office BP and data derived from ABPM at 3 months are summarized in 
ABPM circadian rhythm
According to the circadian rhythm, 22 (17.4%) patients were classified as dippers, 65 (51.5%) non-dippers and 39 (31.1%) reverse dippers. Demographic characteristics of patients, clinical data as well as immunosuppressive treatment and evolution after renal transplantation according to dipping status are summarized in Table 2 . Clinical variables were similar between dipper and non-dipper patients while diabetes before transplantation, BMI and immunosuppression with calcineurin inhibitors were associated with reverse dipper pattern ( Table 2) . In order to evaluate whether reverse dipper pattern was associated with inflammation, serum sTNFR2 and NGAL at baseline, 1 and 3 months were compared between reverse dipper patients and the other two groups (Table 3 ). Higher 33 , P ¼ 0.0197) were independent variables associated with a reverse dipper pattern. However, when sTNFR2 levels and NGAL levels were included in the logistic regression analysis, the only independent predictor of reverse dipper pattern at 3 months was sTNFR2 (RR: 1.19 and 95% CI: 1.03-1.37, P ¼ 0.017).
Relationship between inflammation and clinical data
There was an association between serum sTNFR2 at 3 months and pre-transplant diabetes 23 AE 23 versus 12.1 AE 6.9, P ¼ 0.006), BMI (r ¼ 0.25, P ¼ 0.023), creatinine clearance at 3 months (r ¼ 0.64, P < 0.001) and proteinuria at 3 months (r ¼ 0.39, P < 0.001). Similarly, there was an association between serum NGAL at 3 months and BMI (r ¼ 0.34, P ¼ 0.009), creatinine clearance at 3 months (r ¼ 0.51, P < 0.001) and proteinuria at 3 months (r ¼ 0.32, P ¼ 0.015). There was no association between inflammation markers, patient age or maintenance immunosuppression (data not shown). Stepwise regression analysis showed that pre-transplant diabetes, creatinine clearance and proteinuria at 3 months were independent predictors of sTNFR2 at 3 months (r ¼ 0.66, P < 0.001), while creatinine clearance at 3 months and BMI were independent predictors of serum NGAL at 3 months (r ¼ 0.58, P < 0.001).
ABPM and outcome
There were 12 patients suffering a cardiovascular event at the end of follow-up: myocardial infarction (n ¼ 1), angina (n ¼ 1), ischaemic stroke (n ¼ 3), transient cerebral ischaemic attack (n ¼ 1), congestive heart failure (n ¼ 5) and aortic aneurysm rupture (n ¼ 1). Reverse dipper pattern at 3 months was a risk factor for this complication (RR: 3.65, 95% CI: 1.15-11.5; P ¼ 0.0276). Since the number of cardiovascular events was too low to perform a multivariate Cox regression analysis, a combined outcome variable consisting on the presence of cardiovascular events or graft failure for any reason was defined. During the study period (45 AE 11 months), 22 patients reached the combined outcome variable (Figure 1 ). For censored observations, mean follow-up was 46 AE 8 months (range 34-60). Univariate Cox regression analysis showed that the following variables were associated with the combined outcome variable: donor age, recipient age, recipient BMI, reverse dipper patter, creatinine clearance, proteinuria and sTNFR2 at 3 months (Table 4) . Multivariate Cox regression analysis showed that only creatinine clearance and circadian ABPM pattern were independent predictors of outcome (Table 4) . The statistical power of the association between reverse dipper pattern and the outcome variable was 0.49 (twotailed alpha error of 0.05).
Neither office BP nor different BP measurements derived from the 24-h ABPM were associated with the combined outcome variable.
Discussion
In the present study, we evaluate the utility of ABPM in comparison to office BP to predict patient and graft outcome. Arterial hypertension assessed by means of office determinations constitutes a risk factor for graft failure and cardiovascular events in large cohorts of renal transplant recipients [3] , despite its inaccuracy to properly distinguish white-coat or masked hypertension. In our study, we observed that 53% of patients have uncontrolled hypertension according to the office BP and 71% using the 24-h ABPM. A wide range of BP control has been described in renal transplants. For example, according to 24-h ABPM, uncontrolled hypertension at 1 year ranges between 29 and 95% [14] [15] [16] . Agreement to classify patients as hypertensive or normotensive between office BP and 24-h ABPM was 60% in the present study. The remaining 40% of patients were classified as white-coat hypertension (11%) and masked hypertension (29%). These figures are in agreement with other studies conducted in paediatric [20, 21] and adult renal transplants [22] [23] [24] , confirming that hypertension is more accurately diagnosed by means of 24-h ABPM than office BP. 
a ns, non significant. According to circadian variability of BP, 51% of patients were non-dippers and, noticeably, 31% showed a reverse dipper pattern. Some variability on the prevalence of nondipper pattern has been described [14] [15] [16] [20] [21] [22] [23] [24] , despite it should be taken into consideration that the proportion of non-dippers decreases during the first month as renal function improves [22] [23] [24] . At 3 months, renal function is already stabilized in the majority of patients [25] and possibly, the timing of 24-h ABPM pattern stabilization occurs at this period of follow-up. In this regard, the results on 1-year ABPM pattern reported by Paoletti et al. [15] and Wadei et al. [16] were similar to ours. In these two studies, 16-24% of patients were dippers and 29-34% were reverse dippers, and in our study, 18% were dippers and 31% were reverse dippers. Taking all these data together, we interpret that 3 months is a reasonable period for the early characterization of the BP dipping pattern.
Risk factors associated with reverse dipper pattern in the univariate analysis were pre-transplant diabetes, obesity, use of calcineurin inhibitors and increased levels of sTNFR2 and NGAL. Reverse dipper pattern at 1 year has also been associated with diabetes and obesity in another study [16] . However, multivariate analysis showed that sTNFR2 was the major determinant of ABPM circadian pattern. In the general population, sTNFR2 is increased in diabetic and obese patients [26] and pathophysiologically linked to BP in these subjects and even in the healthy population [27, 28] . In fact, sTNFR2 decreases after lowering BP [29] . Thus, the result of the multivariate analysis may just reflect that low-grade inflammation is a common condition characterizing most frequent comorbidities associated with hypertension and that sTNFR2 is involved in this interaction. On the other hand, renal and systemic vasoconstriction associated with calcineurin inhibitor treatment may be the major reason for its association with ABPM pattern since there is no evidence that calcineurin inhibitors are more closely associated with low-grade inflammation than calcineurin-free immunosuppressive regimens [29] .
In the general population, there is a consistent association between systemic inflammation and hypertension [4] as well as between inflammation and BP circadian rhythm [30] . This was the case in our transplant population suggesting that low-grade inflammation is the link between BP circadian rhythm pattern and end-stage organ damage. Low-grade inflammation in our population depends on recipient characteristics, such as diabetes and obesity, and on renal damage reflected by decreased creatinine clearance and increased proteinuria. Diabetes, obesity and chronic renal failure are well-known pro-inflammatory conditions either in the general population or in renal transplants [31] [32] [33] [34] .
In our study, office BP and parameters derived from 24-h ABPM such as mean SBP, DBP or pulse pressure were not associated with outcome. In some but not all large series of patients, office BP was an independent predictor of patient and allograft survival as well as cardiovascular events [1, 3, [35] [36] [37] [38] [39] [40] . The lack of association between BP and outcome in our series may be related to the relative low number of patients included. On the contrary, reverse dipper pattern was an independent predictor of patient and graft outcome. It is worth to notice that the predictive value of reverse dipper pattern was independent from renal function. A similar result has also been reported in non-dialysis chronic kidney disease patients. In these patients, it has been described that an abnormal dipping pattern is a strong predictor of renal and cardiovascular outcome even after adjusting for traditional cardiovascular risk factors, reinforcing the notion that ABPM has an independent predictive value from other risk factors [12] .
Reverse dipper pattern has been associated with mortality in the general hypertensive population [41] . In renal transplants, it has been associated with renal target organ damage [15, 16, 24] and increased left ventricular mass [42] , two well-known risk factors for graft loss and cardiovascular events [43] . The association between BP circadian rhythm and outcome was rather intense in the present study since the risk to reach the study end point in patients with a reverse dipper pattern was three times higher in comparison to dipper and non-dipper pattern.
Treatment of arterial hypertension after transplantation improves patient and graft survival and reduces cardiovascular events [3] . Our data do not allow exploring whether a better control of BP after 3 months could modify the risk of graft failure or cardiovascular events but raises the question whether the modification of the circadian rhythm of BP in renal transplant recipients by anti-hypertensive treatment could improve renal allograft outcome.
The main limitation of our study is that the statistical power of the association between reverse dipper pattern and the outcome variable was relatively low (0.49). However, it is important to remark that we needed between 3 and 5 years of follow-up to observe 22 events of the combined CrCl, creatinine clearance; ns, non significant.
Reverse dipper pattern and outcome in renal transplantsoutcome variable. To reach a statistical power of 0.80 with the same proportion of event-free patients, 355 patients would be necessary. This large number of patients with a relatively long follow-up would require a multi-centre study. In summary, we show that reverse dipper pattern at 3 months is associated with low-grade inflammation and it is an independent predictor of patient and graft outcome. This observation raises the question whether the modification of the 24-h ABPM should be the target to guide outcome of anti-hypertensive therapy after transplantation.
